Bulletin 64: Dementia drugs

The PrescQIPP drugs for dementia bulletin reviews the evidence and national guidance for the acetylcholinesterase (AChE) inhibitors and aims to provide the rationale for current patients to be switched to different formulations of the same drug with a lower acquisition cost. Support materials are available for organisations to adapt to meet local need.

Loading...